Volume 4, Issue 2 (Fall & Winter 2020)
J Res Urol 2020, 4(2): 71-77 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Alemi M, Matin M, Jafari M, Esna-Ashari F. Evaluation of Postoperative Pathology Results of TURP or Prostatectomy in Patients with Previous Negative Prostatic Biopsies and Elevated Prostate-Specific Antigen Level and Its Role in the Diagnosis of Prostate Cancer. J Res Urol 2020; 4 (2) :71-77
URL: http://urology.umsha.ac.ir/article-1-81-en.html
URL: http://urology.umsha.ac.ir/article-1-81-en.html
1- Assistant Professor, Urology & Nephrology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran , mohsenalemi@yahoo.com
2- General physician, Urology & Nephrology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
3- Associate Professor, Pathology Department, Hamadan University of Medical Sciences, Hamadan, Iran
4- Associate Professor, Social Medicine Department, Hamadan University of Medical Sciences, Hamadan, Iran
2- General physician, Urology & Nephrology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
3- Associate Professor, Pathology Department, Hamadan University of Medical Sciences, Hamadan, Iran
4- Associate Professor, Social Medicine Department, Hamadan University of Medical Sciences, Hamadan, Iran
Abstract: (6331 Views)
Introduction: In cases with previous negative biopsies and a persistently elevated prostate-specific antigen (PSA) level, one of the best method for the definitive diagnosis of prostate cancer is the use of transurethral resection of the prostate (TURP). Therefore, this study aimed to compare the pathology results after the biopsy of such patients with the results obtained from TURP or open prostatectomy.
Materials and Methods: This cross-sectional descriptive study included 95 patients referred to Shahid Beheshti Hospital, Hamadan, Iran, during 2014-19. The participants were selected by a census with a mean age of 68.81±8.38 years with total PSA>3 ng/ml and benign primary biopsy. Following that, they underwent TURP surgery. Data were extracted from hospital archives and recorded in the designed checklist. The variables including age, total and free PSA amount, prostate volume, frequency of biopsy, and the results of TURP or prostatectomy were examined in this study. Student t-test and non-parametric test of Mann-Whitney were used to analyze the data (P< 0.05).
Results: Out of 95 patients studied after TURP or prostatectomy, 4.2% (n=4) of the cases were reported with cancer, and 25% (n=1), 50% (n=2), as well as 25% (n=1) of the patients, had Gleason scores of 5, 6, and 9, respectively, all of which were reported in the initial BPH biopsy. There was no statistically significant difference between cancer and non-cancer groups in terms of age, serum PSA, and prostate volume (P>0.05).
Conclusion: In patients whose PSA levels persistently increase despite previous negative biopsies, the TURP or open prostatectomy method can be used to diagnose prostate cancer more accurately.
Materials and Methods: This cross-sectional descriptive study included 95 patients referred to Shahid Beheshti Hospital, Hamadan, Iran, during 2014-19. The participants were selected by a census with a mean age of 68.81±8.38 years with total PSA>3 ng/ml and benign primary biopsy. Following that, they underwent TURP surgery. Data were extracted from hospital archives and recorded in the designed checklist. The variables including age, total and free PSA amount, prostate volume, frequency of biopsy, and the results of TURP or prostatectomy were examined in this study. Student t-test and non-parametric test of Mann-Whitney were used to analyze the data (P< 0.05).
Results: Out of 95 patients studied after TURP or prostatectomy, 4.2% (n=4) of the cases were reported with cancer, and 25% (n=1), 50% (n=2), as well as 25% (n=1) of the patients, had Gleason scores of 5, 6, and 9, respectively, all of which were reported in the initial BPH biopsy. There was no statistically significant difference between cancer and non-cancer groups in terms of age, serum PSA, and prostate volume (P>0.05).
Conclusion: In patients whose PSA levels persistently increase despite previous negative biopsies, the TURP or open prostatectomy method can be used to diagnose prostate cancer more accurately.
Type of Study: Research |
Subject:
Urologic oncology
Received: 2021/07/23 | Accepted: 2021/08/20 | Published: 2021/09/4
Received: 2021/07/23 | Accepted: 2021/08/20 | Published: 2021/09/4
References
1. Lujan M, Paez A, Llanes L, Miravalles E, Berenguer A. Prostate specific antigen density. Is there a role for this parameter when screening for prostate cancer?. Prostate cancer and prostatic diseases. 2001;4(3):146-9. [DOI:10.1038/sj.pcan.4500509] [PMID]
2. Hosseini M, Jahani Y, Mahmoudi M, Eshraghian MR, Yahyapour Y, Keshtkar AA. The Assessment Of Risk Factors For Prostate Cancer In Mazandaran Province, Iran. 2008.
3. Björk T, Nilsson O, Dahlén U, Matikainen MT, Cockett AT, Abrahamsson PA, Lilja H. Serum prostate specific antigen complexed to α1-antichymotrypsin as an indicator of prostate cancer. Urol. J. 1993;150(1):100-5. [DOI:10.1016/S0022-5347(17)35408-3]
4. Nguyen K, Sabata B, Jain AK. Prostate cancer grading: Gland segmentation and structural features. Pattern Recognit Lett. 2012;33(7):951-61. [DOI:10.1016/j.patrec.2011.10.001]
5. Partin AW, Oesterling JE. The clinical usefulness of prostate specific antigen: update 1994. J. Urol. 1994;152(5):1358-68. [DOI:10.1016/S0022-5347(17)32422-9]
6. Catalona WJ, Richie JP, Ahmann FR, Hudson ML, Scardino PT, Flanigan RC, Dekernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J. Urol. 1994;151(5):1283-90. [DOI:10.1016/S0022-5347(17)35233-3]
7. Djavan BO, Waldert M, Zlotta A, Dobronski P, Seitz C, Remzi M, Borkowski A, SCHULMAN C, MARBERGER M. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J. Urol. 2001;166(3):856-60.
https://doi.org/10.1097/00005392-200109000-00013 [DOI:10.1016/S0022-5347(05)65851-X]
8. Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N, Schmid HP, Van Der Kwast T, Wiegel T, Zattoni F. EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease. Actas Urol. Esp. 2011;35(9):501-14. [DOI:10.1016/j.acuroe.2011.12.003]
9. Mahdavi R, Aghamohammadpour K, Ghoreifi Sa. The Role Of Transurethral Resection Of Prostate In Detecting Prostate Cancer In Patients With Previously Negative Biopsy, Elevated Psa Levels And Positive Lower Urinary Tract Symptoms. Stud Med Sci. 2012;23(2):178-82. [DOI:10.1016/S1569-9056(13)60273-0]
10. Babaian RJ. Extended field prostate biopsy enhances cancer detection. J. Urol. 2000;55(4):453-6. [DOI:10.1016/S0090-4295(00)00469-6]
11. Carter HB, Hamper UM, Sheth S, Sanders RC, Epstein JI, Walsh PC. Evaluation of transrectal ultrasound in the early detection of prostate cancer. J. Urol. 1989;142(4):1008-10. [DOI:10.1016/S0022-5347(17)38971-1]
12. Radhakrishnan S, Dorkin TJ, Sheikh N, Greene DR. Role of transition zone sampling by TURP in patients with raised PSA and multiple negative transrectal ultrasound-guided prostatic biopsies. Prostate cancer and prostatic diseases. 2004;7(4):338-42. [DOI:10.1038/sj.pcan.4500756] [PMID]
13. Eggener SE, Roehl KA, Catalona WJ. Predictors of subsequent prostate cancer in men with a prostate specific antigen of 2.6 to 4.0 ng/ml and an initially negative biopsy. J. Urol. 2005;174(2):500-4. [DOI:10.1097/01.ju.0000165203.40973.0f] [PMID]
14. Jyoti SK, Blacke C, Patil P, Amblihalli VP, Nicholson A. Prostate cancer screening by prostate-specific antigen (PSA); a relevant approach for the small population of the Cayman Islands. Cancer Causes & Control. 2018;29(1):87-92. [DOI:10.1007/s10552-017-0963-2] [PMID]
15. Samad A, Fayyaz N, Siddiqa A, Akhter N, Saeed R, Rafiq M, Bukhari AA, Afzal A. Association of Serum PSA Levels with Histopathological Pattern of Prostate Lesions. J Islamabad Med Dent College. 2019;8(2):92-5. [DOI:10.35787/jimdc.v8i2.362]
16. Mahdavi R, Aghamohammadpour K, Shakibi MH. The Result of Transrectal Ultrasound Guided 10-14 Cores Biopsies of the Prostate. MUMS. 2011;54(3):172-6.
17. Yates DR, Gregory GC, Roupret M, Malki MM, Haynes MD, Hamdy FC, Rosario DJ. Transurethral resection biopsy as part of a saturation biopsy protocol: a cohort study and review of the literature. InUrologic Oncology: Seminars and Original Investigations 2013 (Vol. 31, No. 5, pp. 542-548). Elsevier. [DOI:10.1016/j.urolonc.2011.02.008] [PMID]
18. Cho HJ, Shin SC, Cho JM, Kang JY, Yoo TK. The role of transurethral resection of the prostate for patients with an elevated prostate-specific antigen. Prostate Int. 2014;2(4):196-202. [DOI:10.12954/PI.14060] [PMID] [PMCID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s).
Owned by Hamadan University of Medical Sciences.
Published by UMSHA Press
Journal Tel: +9881 38380283
Publisher Tel: +988138380548
Website: http://urology.umsha.ac.ir
Email: urology [at]umsha.ac.ir
